Nitazoxanide in the treatment of chronic cutaneous leishmaniasis resistant to traditional sodium stibogluconate

Journal of the American Academy of Dermatology

Volumn 64, Issue 1, 2011, Pages 202-203

  Gurgen, Johnny ^a   Hogan, Daniel ^b   Grace, Edward ^b   Johnson, David ^b  

^a NOVA SOUTHEASTERN UNIVERSITY   (United States)

^b Bay Pines Veterans Affairs Healthcare System   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITAZOXANIDE; STIBOGLUCONATE SODIUM;

ADULT; ANAMNESIS; CASE REPORT; CHRONIC DISEASE; CLINICAL FEATURE; DRUG TREATMENT FAILURE; HISTIOCYTE; HISTOPATHOLOGY; HUMAN; LETTER; MALE; PRIORITY JOURNAL; SKIN LEISHMANIASIS;

EID: 78650315100     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2009.06.044     Document Type: Article

References (5)

1. U. González, M. Pinart, L. Reveiz, and J. Alvar Interventions for Old World cutaneous leishmaniasis Cochrane Database Syst Rev 4 2008 CD005067
2. S. Sundar, T.K. Jha, C.P. Thakur, J. Engel, H. Sindermann, and C. Fischer Oral miltefosine for Indian visceral leishmaniasis N Engl J Med 347 2002 1739 1746
3. J.F. Rossignol, A. Elfert, Y. El-Gohary, and E.B. Keeffe Improved virologic response in chronic hepatitis C genotype 4 treated with nitazoxanide, peginterferon, and ribavirin Gastroenterology 136 2009 856 862
4. J.F. Rossignol, and E.B. Keeffe Thiazolides: a new class of drugs for the treatment of chronic hepatitis B and C Future Microbiol 3 2008 539 545
5. S. Aslam, and D.M. Musher Nitazoxanide: clinical studies of a broad-spectrum anti-infective agent Future Microbiol 2 2007 583 590